JP2022507186A5 - - Google Patents

Info

Publication number
JP2022507186A5
JP2022507186A5 JP2021525640A JP2021525640A JP2022507186A5 JP 2022507186 A5 JP2022507186 A5 JP 2022507186A5 JP 2021525640 A JP2021525640 A JP 2021525640A JP 2021525640 A JP2021525640 A JP 2021525640A JP 2022507186 A5 JP2022507186 A5 JP 2022507186A5
Authority
JP
Japan
Prior art keywords
magnetic particles
research
european
erc
funded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021525640A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022507186A (ja
Filing date
Publication date
Priority claimed from GBGB1818421.8A external-priority patent/GB201818421D0/en
Application filed filed Critical
Publication of JP2022507186A publication Critical patent/JP2022507186A/ja
Publication of JP2022507186A5 publication Critical patent/JP2022507186A5/ja
Priority to JP2024135576A priority Critical patent/JP7661591B2/ja
Pending legal-status Critical Current

Links

JP2021525640A 2018-11-12 2019-11-11 磁性粒子および方法 Pending JP2022507186A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024135576A JP7661591B2 (ja) 2018-11-12 2024-08-15 磁性粒子および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1818421.8A GB201818421D0 (en) 2018-11-12 2018-11-12 Magnetic particle and method
GB1818421.8 2018-11-12
PCT/GB2019/053188 WO2020099846A1 (en) 2018-11-12 2019-11-11 Magnetic particle and method

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024135576A Division JP7661591B2 (ja) 2018-11-12 2024-08-15 磁性粒子および方法

Publications (2)

Publication Number Publication Date
JP2022507186A JP2022507186A (ja) 2022-01-18
JP2022507186A5 true JP2022507186A5 (enExample) 2022-09-22

Family

ID=64739572

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021525640A Pending JP2022507186A (ja) 2018-11-12 2019-11-11 磁性粒子および方法
JP2024135576A Active JP7661591B2 (ja) 2018-11-12 2024-08-15 磁性粒子および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024135576A Active JP7661591B2 (ja) 2018-11-12 2024-08-15 磁性粒子および方法

Country Status (6)

Country Link
US (2) US11640865B2 (enExample)
EP (1) EP3881341A1 (enExample)
JP (2) JP2022507186A (enExample)
CN (1) CN113016044A (enExample)
GB (1) GB201818421D0 (enExample)
WO (1) WO2020099846A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025541839A (ja) 2022-12-08 2025-12-23 セマリオン リミテッド キャリア、キャリアシステム及び方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH095326A (ja) 1995-06-22 1997-01-10 Ss Pharmaceut Co Ltd 金コロイド免疫測定法
US6337215B1 (en) 1997-12-01 2002-01-08 International Business Machines Corporation Magnetic particles having two antiparallel ferromagnetic layers and attached affinity recognition molecules
JP2001332421A (ja) 2000-03-16 2001-11-30 Toda Kogyo Corp 磁性薄膜及び該磁性薄膜の製造法
US7015047B2 (en) * 2001-01-26 2006-03-21 Aviva Biosciences Corporation Microdevices having a preferential axis of magnetization and uses thereof
US6902807B1 (en) * 2002-09-13 2005-06-07 Flex Products, Inc. Alignable diffractive pigment flakes
GB0215185D0 (en) 2002-07-01 2002-08-07 Genovision As Binding a target substance
EP1662256A1 (en) 2004-11-25 2006-05-31 Spinomix S.A. Tailored magnetic particles and method to produce same
EP2073940A2 (en) 2006-08-17 2009-07-01 The Regents of the University of California Customized lithographic particles
AU2008219354B2 (en) * 2007-09-19 2014-02-13 Viavi Solutions Inc. Anisotropic magnetic flakes
FR2950042B1 (fr) * 2009-09-17 2012-01-13 Commissariat Energie Atomique Procede de fabrication d?une microparticule et microparticule ainsi fabriquee
EP2375242A1 (en) 2010-04-06 2011-10-12 FOM Institute for Atomic and Moleculair Physics Integrated plasmonic nanocavity sensing device
FR2958791A1 (fr) 2010-04-12 2011-10-14 Commissariat Energie Atomique Procede de fabrication de particules telles que des micro ou nanoparticules magnetiques
US9040310B2 (en) 2010-04-27 2015-05-26 Ventana Medical Systems, Inc. Antibody-nanoparticle conjugates and methods for making and using such conjugates
WO2013078452A1 (en) 2011-11-22 2013-05-30 University Of Maryland, Baltimore Plasmonic Substrates for Metal-Enhanced Fluorescence Based Sensing, Imaging and Assays
US10175199B2 (en) * 2012-11-15 2019-01-08 Micro-Tracers, Inc. Tracer particles, and methods for making same
ES2656987T3 (es) * 2012-11-16 2018-03-01 Quanta Matrix Co., Ltd. Micropartículas de polímero codificadas
WO2014160175A1 (en) 2013-03-14 2014-10-02 The Board Of Trustees Of The Leland Stanford Junior University Plasmonic substrate for multiplex assessment of type 1 diabetes
KR20150074647A (ko) 2013-12-24 2015-07-02 한국조폐공사 위변조 방지기능을 가지는 ２차원 바코드 및 그 제조방법
CN111381031B (zh) * 2014-12-16 2023-09-29 埃因霍温科技大学 基于拴系颗粒的生物传感器及感测分析物的方法
US9667034B1 (en) 2016-06-27 2017-05-30 Elwha Llc Enhanced photoluminescence
JP2018152449A (ja) * 2017-03-13 2018-09-27 株式会社東芝 複数の扁平磁性金属粒子、圧粉材料及び回転電機
FR3079744B1 (fr) * 2018-04-05 2020-04-03 Commissariat A L'energie Atomique Et Aux Energies Alternatives Procede de fabrication d’un fluide biocompatible comportant une poudre de particules magnetiques, fluide biocompatible comportant une poudre de particules magnetiques

Similar Documents

Publication Publication Date Title
LTC2567976I2 (lt) Antikūnai prieš CD38 antigeną, skirti išsėtinės mielomos gydymui
WO2017009308A3 (en) Antibodies specific for hyperphosphorylated tau and methods of use thereof
JP2013539454A5 (enExample)
JP2016500251A5 (enExample)
JP2007051159A5 (enExample)
DE602006006200D1 (de) Antikörper gegen 25-hydroxyvitamin d
PH12016500859B1 (en) Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
TN2018000419A1 (en) Antibodies specific for hyperphosphorylated tau and methods of use thereof.
WO2010010466A3 (en) Neutralizing anti-influenza a virus antibodies and uses thereof
EP3266464A3 (en) Yeast-based therapeutic for chronic hepatitis b infection
NZ613370A (en) Combinations for treating hcv
NO20064826L (no) Indazoler, benzotiazoler, benzoisotiazoler, benzisoksazoler og fremstilling og anvendelse derav
MY147217A (en) Antibody molecules having specificity for human il-06
JOP20210044A1 (ar) الأجسام المضادة لـ cd38
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
WO2015050959A8 (en) Anti-kit antibodies and methods of use thereof
MY199017A (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy
ATE517340T1 (de) Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren
JP2019516789A5 (enExample)
NO20061412L (no) Terapi av okulaere foretyrrelser
WO2018071822A3 (en) Antibodies that bind zika virus envelope protein and uses thereof
WO2010028072A3 (en) Avian antibodies specific to influenza virus and technologically simple methods of their manufacture and use
JP2015500805A5 (enExample)
JP2016053063A5 (enExample)
JP2021530507A5 (enExample)